Advanced Proteome Therapeutics (TSXV:APC.H) Scaled Net Operating Assets : -0.09 (As of Apr. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Advanced Proteome Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Advanced Proteome Therapeutics's operating assets for the quarter that ended in Apr. 2023 was C$0.03 Mil. Advanced Proteome Therapeutics's operating liabilities for the quarter that ended in Apr. 2023 was C$0.07 Mil. Advanced Proteome Therapeutics's Total Assets for the quarter that ended in Jan. 2023 was C$0.44 Mil. Therefore, Advanced Proteome Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Apr. 2023 was -0.09.

Advanced Proteome Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Advanced Proteome Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Scaled Net Operating Assets Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Scaled Net Operating Assets

Get a 7-Day Free Trial

-5.64

-4.62

-6.70

-118.59

-1.22

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Scaled Net Operating Assets	Get a 7-Day Free Trial															-1.53	-1.27	-1.40	-2.54	-0.09

Competitive Comparison of Advanced Proteome Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Scaled Net Operating Assets falls into.

Advanced Proteome Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Advanced Proteome Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jul. 2022 )
=	(Operating Assets (A: Jul. 2022 )	-	Operating Liabilities (A: Jul. 2022 ))	/	Total Assets (A: Jul. 2021 )
=	(0.119	-	1.495)	/	1.125
=	-1.22

where

	Operating Assets		(A: Jul. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.823	-	0.704
=	0.119

	Operating Liabilities		(A: Jul. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.924	-	0.294	-	0.135
=	1.495

Advanced Proteome Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Apr. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Apr. 2023 )
=	(Operating Assets (Q: Apr. 2023 )	-	Operating Liabilities (Q: Apr. 2023 ))	/	Total Assets (Q: Jan. 2023 )
=	(0.032	-	0.071)	/	0.438
=	-0.09

where

	Operating Assets		(Q: Apr. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.085	-	0.053
=	0.032

	Operating Liabilities		(Q: Apr. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.113	-	0	-	0.042
=	0.071

Advanced Proteome Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (TSXV:APC.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (TSXV:APC.H) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

0E81:Germany

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (TSXV:APC.H) Headlines

No Headlines